Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
3-trifluoromethyl-4-nitro-5-arylpyrazoles are novel K(ATP) channel agonistsAndrew J Peat, Claire Townsend, M Craig McKay, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Novel GSK-3 inhibitors with improved cellular activityAndrew J Peat, Dulce Garrido, Joyce A Boucheron, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2006
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3Terrence L Smalley, Andrew J Peat, Joyce A Boucheron, et al.Journal of Medicinal Chemistry|November 10, 2012
Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptasePek Chong, Paul Sebahar, Michael Youngman, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Synthesis and evaluation of 7-substituted-3-cyclobutylamino-4H-1,2,4-benzothiadiazine-1,1-dioxide derivatives as K(ATP) channel agonistsAndrew J Peat, Claire Townsend, Jennings F Worley, et al.Bioorganic & Medicinal Chemistry Letters|April 16, 2014
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinVincent W-F Tai, Dulce Garrido, Daniel J Price, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitorsAndrew J Peat, Joyce A Boucheron, Scott H Dickerson, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical CharacterizationJ Brad Shotwell, Subramanian Baskaran, Pek Chong, et al.Pageof 1